Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Steroid-Insensitive Gene Expression of Extracellular Matrix Components and Pro-fibrotic Factors in the Lung Associated with Airway Hyperresponsiveness in Murine Asthma.
Biol Pharm Bull. 2024;47(1):227-231. doi: 10.1248/bpb.b23-00768.
Biol Pharm Bull. 2024.
PMID: 38246609
Free article.
JPH203, a LAT1 inhibitor, alleviates steroid-resistant murine airway inflammation mediated by Th17 cells.
Hayashi K, Saeki M, Miura K, Yamasaki N, Matsuda M, Shimora H, Nabe T, Shimizu Y, Fujita T, Endou H, Kaminuma O.
Hayashi K, et al. Among authors: shimora h.
Allergy. 2023 Oct;78(10):2780-2783. doi: 10.1111/all.15798. Epub 2023 Jun 29.
Allergy. 2023.
PMID: 37382229
No abstract available.
Item in Clipboard
Ceramide Nanoliposomes as Potential Therapeutic Reagents for Asthma.
Sakae H, Ogiso Y, Matsuda M, Shimora H, Deering T, Fox TE, Kester M, Nabe T, Kitatani K.
Sakae H, et al. Among authors: shimora h.
Cells. 2023 Feb 11;12(4):591. doi: 10.3390/cells12040591.
Cells. 2023.
PMID: 36831258
Free PMC article.
Item in Clipboard
Local IL-10 replacement therapy was effective for steroid-insensitive asthma in mice.
Matsuda M, Inaba M, Hamaguchi J, Tomita H, Omori M, Shimora H, Sakae H, Kitatani K, Nabe T.
Matsuda M, et al. Among authors: shimora h.
Int Immunopharmacol. 2022 Sep;110:109037. doi: 10.1016/j.intimp.2022.109037. Epub 2022 Jul 8.
Int Immunopharmacol. 2022.
PMID: 35810490
Item in Clipboard
Pathogenic changes in group 2 innate lymphoid cells (ILC2s) in a steroid-insensitive asthma model of mice.
Matsuda M, Tanaka Y, Shimora H, Takemoto N, Nomura M, Terakawa R, Hashimoto K, Sakae H, Kanda A, Iwai H, Kitatani K, Nabe T.
Matsuda M, et al. Among authors: shimora h.
Eur J Pharmacol. 2022 Feb 5;916:174732. doi: 10.1016/j.ejphar.2021.174732. Epub 2021 Dec 28.
Eur J Pharmacol. 2022.
PMID: 34971621
Item in Clipboard
Sublingual immunotherapy for 4 years increased the number of Foxp3+ Treg cells, which correlated with clinical effects.
Terada T, Matsuda M, Inaba M, Hamaguchi J, Takemoto N, Kikuoka Y, Inaka Y, Sakae H, Hashimoto K, Shimora H, Kitatani K, Kawata R, Nabe T.
Terada T, et al. Among authors: shimora h.
Inflamm Res. 2021 May;70(5):581-589. doi: 10.1007/s00011-021-01460-3. Epub 2021 Apr 9.
Inflamm Res. 2021.
PMID: 33837438
Clinical Trial.
Item in Clipboard
Cite
Cite